IDEXX Laboratories/ US45168D1046 /
29/08/2024 21:59:59 | Chg. +5.64 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
487.49USD | +1.17% | 20,108 Turnover: 9.84 mill. |
-Bid Size: - | -Ask Size: - | 40.11 bill.USD | - | 47.91 |
Assets
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | - | 216.8000 | 245.2000 | 281.2000 | 303.5870 | ||||||
Intangible Assets | - | 69.2000 | 62.8000 | 58.8000 | 65.1220 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | - | 624.8130 | ||||||
Inventories | - | 133.1000 | 140.9000 | 133.4000 | 160.3420 | ||||||
Accounts Receivable | - | 141.3000 | 138.3000 | 158 | 152.3800 | ||||||
Cash and Cash Equivalents | - | 183.9000 | 224 | 279.1000 | 322.5360 | ||||||
Current Assets | - | 524.2000 | 569.5000 | 652.7000 | 759.3980 | ||||||
Total Assets | - | 1,030.8000 | 1,103.6000 | 1,230.5000 | 1,384.2110 |
Liabilities
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | - | 36.6000 | 35.3000 | 29.9000 | 44.7430 | ||||||
Long-term debt | - | - | - | - | 350 | ||||||
Liabilities to Banks | - | 243 | 212 | 277 | 549 | ||||||
Provisions | - | 141.4000 | 137.7000 | 148.9000 | 195.4000 | ||||||
Liabilities | - | 491.2000 | 467.3000 | 712.3000 | 1,266.6220 | ||||||
Share Capital | - | 9.9000 | 10 | 10.1190 | 20.3900 | ||||||
Total Equity | - | 539.6000 | 636.3000 | 518.2000 | 117.5890 | ||||||
Minority Interests | - | 0.0000 | 0.0000 | .0300 | .0730 | ||||||
Total liabilities equity | - | 1,030.8000 | 1,103.6000 | 1,230.5000 | 1,384.2110 |
Income Statement
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,103.4000 | 1,218.7000 | 1,293.3000 | 1,377.1000 | 1,485.8070 | ||||||
Depreciation (total) | - | - | - | - | 58.8880 | ||||||
Operating Result | 203.9000 | 236.2000 | 262.6000 | 266.8000 | 260.2550 | ||||||
Interest Income | -1.7000 | -1.8000 | -1.9000 | -3.5000 | -13.7000 | ||||||
Income Before Taxes | 202.1000 | 234.4000 | 260.6000 | 263.3000 | 246.5550 | ||||||
Income Taxes | 60.8000 | 72.7000 | 82.3000 | 75.5000 | 64.6040 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | .0450 | ||||||
Net Income | 141.3000 | 161.8000 | 178.3000 | 187.8000 | 181.9060 |
Per Share
Cash Flow
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 178.8000 | 220.7000 | 230.3000 | 246 | 235.8460 | ||||||
Cash Flow from Investing Activities | -43.2000 | -97 | -66 | -86.1000 | -80.4130 | ||||||
Cash Flow from Financing | -86.8000 | -97.7000 | -125.3000 | -102.5000 | -103.4380 | ||||||
Decrease / Increase in Cash | 50.2000 | 27 | 40.1000 | 55.1000 | 43.4780 | ||||||
Employees | 4,800 | 5,100 | 5,400 | 5,700 | 6,400 |